"Somos un Centro Público cuya Misión Principal es la Investigación del Cáncer y trasladar la tecnología innovadora al Sistema Nacional de Salud."

During the past decade, Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" #1 sponsor was "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 4 trials, followed by "Celgene" with 1 trials sponsored, "LTN PHARMACEUTICALS, INC." with 1 trials sponsored, "Mast Therapeutics, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" #1 collaborator was "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" are "Advanced Prostate Cancer" (4 trials), "Castration Resistant" (2 trials), "Abiraterone ACetate" (1 trials), "Cabazitaxel" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" in a lesser frequency.

Most popular intervention types in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Antibiotic" (1 trials), "Enzalutamide" (1 trials), "Galeterone" (1 trials), "MST-188" (1 trials) and "Radium 223 55mBq/Kg every 4 weeks intravenously" (1 trials). Other intervention names were less common.

The vast majority of trials in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas" are 5 trials for "Male" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".